Mounjaro kick-started my weight loss, but true success came from hard work, persistence and changing bad habits ...

Landmark trials have shown that GLP-1 receptor agonists, originally developed for diabetes and weight loss, also provide ...

Patients prescribed drugs to help them lose weight may experience a rebound in weight gain after halting their prescription, ...

The review that pooled the results of 11 studies has found that people started regaining weight two months after stopping the ...

For adults with type 2 diabetes and obesity, glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with a lower risk for dementia, stroke, and all-cause mortality compared with other ...

Menopause can feel like one big balancing act. Between managing your hormone levels and symptoms like hot flashes, night ...

Clinical trial data review on weight-loss drugs reveals weight regain patterns post-medication discontinuation, impacting weight management strategies.

For adults with type 2 diabetes and obesity, glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with a ...

A WOMAN who lost a staggering five stone thanks to weight-loss jabs has hit back at trolls who brand her an “Ozempic cheat”.

Explore how semaglutide and tirzepatide may protect against dementia and stroke—keep reading for clinical implications and evidence.

Tirzepatide was superior to semaglutide in achieving standard and intensive cardiometabolic targets among patients with type 2 diabetes.

Hydreight Technologies Inc. (TSXV: NURS | OTCQB: HYDTF | FSE: SO6) ('Hydreight” or the 'Company”), a telehealth and mobile medical company operating across the U.S. focused on expanding access to care ...